Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lung Neoplasms × Ketamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 7 Neoplasms 7 Pain, Postoperative 4 Depression 3 Breast Neoplasms 3 Agnosia 3 Pain, Intractable 2 Chronic Pain 2 Acute Pain 2 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Analgesia 1 Peripheral Nervous System Diseases 1 Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Neuralgia 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Hypoxia 1 Emergence Delirium 1 Depressive Disorder, Major 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Cancer Pain 1 Abdominal Cancer 1

Interventions

Carboplatin 152 Paclitaxel 111 Radiotherapy 110 Cisplatin 101 Docetaxel 85 Gemcitabine 76 Pemetrexed 72 Erlotinib Hydrochloride 70 Bevacizumab 45 Etoposide 38 pembrolizumab 31 Vinorelbine 30 Topotecan 28 Gefitinib 26 Irinotecan 25 Surveys and Questionnaires 23 Radiosurgery 18 Magnetic Resonance Spectroscopy 18 Drug Therapy 18 Nivolumab 17 Cetuximab 16 durvalumab 15 Cyclophosphamide 15 Surgical Procedures, Operative 14 Immunohistochemistry 14 Celecoxib 14 Gene Expression Profiling 13 Filgrastim 13 Early Intervention, Educational 13 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00504725 2014-07-25

KITS

Duke University

Phase 2 Completed

40 enrolled 7 charts

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡